Trademark applications and grants for Coherus Biosciences Inc. Coherus Biosciences Inc has 50 trademark applications. The latest application filed is for "a symbol or image mark"
Patent Application | Date |
---|---|
COMPOSITIONS AND METHODS TO TREAT NON-ALCOHOLIC FATTY LIVER DISEASES (NAFLD) 20220288054 - 17/600182 Mantzoros; Christos ;   et al. | 2022-09-15 |
COMPOSITIONS AND METHODS TO TREAT NON-ALCOHOLIC FATTY LIVER DISEASES (NAFLD) 20220288053 - 17/600178 Mantzoros; Christos ;   et al. | 2022-09-15 |
COMPOSITIONS AND METHODS TO TREAT CANCER 20220202804 - 17/613012 Rosen; Glenn D. | 2022-06-30 |
METHOD OF PRODUCING A RECOMBINANT PROTEIN 20220195029 - 17/608204 Modi; Robin ;   et al. | 2022-06-23 |
COMPOSITIONS AND METHODS TO TREAT NON-ALCOHOLIC FATTY LIVER DISEASES (NAFLD) 20220193102 - 17/600168 Mantzoros; Christos | 2022-06-23 |
NCAGE Code | 88J79 | COHERUS BIOSCIENCES, INC. |
CAGE Code | 88J79 | COHERUS BIOSCIENCES, INC. |
S.A.M. Registration | 88J79 [78502849] | COHERUS BIOSCIENCES, INC. |
SEC | 0001512762 | Coherus BioSciences, Inc. of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.